Neurohormonal and Transcatheter Repair Strategies for Proportionate and Disproportionate Functional Mitral Regurgitation in Heart Failure

JACC Heart Fail. 2019 Jun;7(6):518-521. doi: 10.1016/j.jchf.2019.03.016. Epub 2019 May 8.

Authors

Milton Packer¹, Paul A Grayburn²

Affiliations

¹ Division of Cardiology, Department of Internal Medicine and the Baylor Scott and White Heart and Vascular Hospital, Baylor University Medical Center, Dallas, Texas; Imperial College, London, United Kingdom. Electronic address: milton.packer@baylorhealth.edu.
² Division of Cardiology, Department of Internal Medicine and the Baylor Scott and White Heart and Vascular Hospital, Baylor University Medical Center, Dallas, Texas.

PMID: 31078484
DOI: 10.1016/j.jchf.2019.03.016

No abstract available

Keywords: mitral regurgitation; mitral valve repair; neurohormonal antagonists.

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Angiotensin Receptor Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Cardiac Catheterization
Cardiac Resynchronization Therapy
Heart Failure / complications
Heart Failure / physiopathology
Heart Failure / therapy*
Humans
Hypertrophy, Left Ventricular / complications
Hypertrophy, Left Ventricular / physiopathology
Hypertrophy, Left Ventricular / therapy*
Mitral Valve Annuloplasty*
Mitral Valve Insufficiency / etiology
Mitral Valve Insufficiency / physiopathology
Mitral Valve Insufficiency / therapy*
Papillary Muscles
Ventricular Dysfunction, Left / complications
Ventricular Dysfunction, Left / physiopathology
Ventricular Dysfunction, Left / therapy*
Ventricular Remodeling

Substances

Adrenergic beta-Antagonists
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors